Company law change could cost pharma firms millions
• Companies say they will need regulatory approval in dozens of countries if forced to alter leaflets • Change could cause supply issues, businesses claim
A minor change to Irish company law could result in higher global drug prices and cost tens of millions of euro, a number of major pharmaceutical companies have warned the government.
Several of the country’s biggest multinational employers are seeking an exemption to new rules requiring them to change the identifier at the end of their legal names. The drug companies have argued that should they be required to include descriptions such as ...
